Clinical Trial Update: Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 trial in subjects with kidney dysfunction evaluated the pharmacokinetic behavior of Met DR; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Met DR

Snippet

Sponsor: Elcelyx Therapeutics, Inc. | Conditions: Renal Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2015-12-30